Abstract
Implementation and adherence to consensus statement criteria for referral of pediatric cancer patients for genetic evaluation are critical to identify the 5% to 10% with a genetic cancer predisposition syndrome. The authors implemented a Plan-Do-Study-Act quality improvement initiative aimed at increasing referrals of at-risk patients. Retrospective chart review was followed by educational intervention - with impact assessed over a 9-month prospective chart review. Referral rate improved >2-fold and there was an improvement in documented oncologic history to at least a third-degree relative. The integration of quality improvement can be an effective tool to improve the referral of patients with an elevated risk for a cancer predisposition syndrome.
Original language | English (US) |
---|---|
Pages (from-to) | E891-E896 |
Journal | Journal of Pediatric Hematology/Oncology |
Volume | 43 |
Issue number | 6 |
DOIs | |
State | Published - Aug 2021 |
Keywords
- cancer predisposition syndromes
- family history
- germline testing
- oncologic genetics
- quality improvement
ASJC Scopus subject areas
- Hematology
- Oncology
- Pediatrics, Perinatology, and Child Health